Therapy of choice for diffuse toxic goiter in a patient over 55 years:
## **Core Concept**
Diffuse toxic goiter, also known as Graves' disease, is an autoimmune disorder that leads to hyperthyroidism. The primary goal of treatment is to reduce thyroid hormone production or its effects on the body. In patients over 55 years, the management approach may differ due to comorbidities and potential side effects of treatments.
## **Why the Correct Answer is Right**
Radioactive iodine ablation is often considered the therapy of choice for diffuse toxic goiter (Graves' disease) in patients over 55 years. This method works by destroying part of the thyroid gland, which leads to a decrease in thyroid hormone production. It is effective, has a low risk of complications when used appropriately, and avoids the long-term risks associated with antithyroid medications or surgery.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although antithyroid medications can be used to manage Graves' disease, they are not typically the first choice for long-term management in patients over 55 due to potential side effects and the need for prolonged treatment.
- **Option B:** This option is incorrect as it does not provide a recognized treatment for Graves' disease.
- **Option C:** This option might seem plausible but is not specified; however, given that the correct answer involves radioactive iodine, any other option not involving this or standard treatments like surgery or antithyroid drugs would be incorrect.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that radioactive iodine ablation is a preferred long-term treatment for Graves' disease, especially in older adults, due to its efficacy and safety profile. It's essential to assess patients for contraindications, such as pregnancy or breastfeeding, before administering radioactive iodine.
## **Correct Answer:** . Radioactive Iodine Ablation